Intellective Bio.
Milestones
Milestones
China Future Healthcare Rankings 2020-2021-Top 100 Biomedicine Companies
Rising Star of China Biomedicine CDMO Enterprises in 2020
2022 Top Brands of Chinese Life Science Service Enterprises
"Potential Unicorn" enterprises in Jiangsu
  • 2024

    The first commercial production project was approved.

  • 2023

    The Changshu site passed the EU QP inspection.

    Honored as a National-level Specialized,Refinement,Distinctive and lnnovative(SRDI)enterprise.

    The CEO of lntellectiveBio attended the APEC CEO summit in San Francisco aS a business leader representative.

    The first complete ADC project was accepted by NMPA.

  • 2022

    Completed the first batch of 6,000 L production.

    The headquaters in Changshu has commenced operations,with a tOtal planned capacity 220,000 L

    Completed the first BLA submission.

  • 2021

    The Xiangcheng site passed the EU QP inspection.

    The Suzhou lndustrial Park site has commenced production, with a tOtal capacity reaching 22,000 L.

  • 2020

    Passed EU QP certification and ISO quality system certification.

    Completed the first batch of 2000 L production.

    Obtained the first FDA clinical trial approval.

  • 2019

    Completed the first batch of 500 L production.

    5700 L GMP workshop put into operation.

    Obtained the first NMPA clinical trial approval.

  • 2018

    lntellectiveBio was registered and established in Xiangcheng,SuZhou.

    Completed the first batch of 200 L production.

Find out how we can contribute to your success!
TOP
Copyright © Intellective Bio. All Rights Reserved ICP:苏ICP备19044439号-1